Cargando…

SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma

BACKGROUND: Malignant mesothelioma is an aggressive, treatment-resistant tumor arising from mesothelium of pleura, peritoneum and pericardium. Despite current combined regimen, its prognosis remains dismal, calling for more effective targeted therapies. We investigated whether aberrant Hh activation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yi, He, Jianxing, Zhang, Fang, Li, Hui, Yue, Dongsheng, Wang, Changli, Jablons, David M, He, Biao, Lui, Natalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622612/ https://www.ncbi.nlm.nih.gov/pubmed/23379358 http://dx.doi.org/10.1186/1756-9966-32-7

Ejemplares similares

SMO mutations confer poor prognosis in malignant pleural mesothelioma
por: Signorelli, Diego, et al.
Publicado: (2020)

Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma
por: Li, Hui, et al.
Publicado: (2013)

Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
por: Woodard, Gavitt A., et al.
Publicado: (2020)

Prognostic factors for progression‐free and overall survival in malignant pleural mesothelioma
por: Guzmán‐Casta, Jordi, et al.
Publicado: (2021)

Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma
por: HIRATA, TOMOMI, et al.
Publicado: (2015)

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
por: Quetel, Lisa, et al.
Publicado: (2020)

DNA Methylation of FKBP5 as Predictor of Overall Survival in Malignant Pleural Mesothelioma
por: Cugliari, Giovanni, et al.
Publicado: (2020)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

High Expression of SMO and GLI1 Genes with Poor Prognosis in Malignant Mesothelioma
por: Ma, Guan-Ying, et al.
Publicado: (2023)

Does size matter? —a population-based analysis of malignant pleural mesothelioma
por: He, Jiaxi, et al.
Publicado: (2020)

Cul4A is an oncogene in malignant pleural mesothelioma
por: Hung, Ming-Szu, et al.
Publicado: (2011)

DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma
por: Wang, Hui, et al.
Publicado: (2017)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
por: Zhang, Shulin, et al.
Publicado: (2014)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Survival Effect of Complete Multimodal Therapy in Malignant Pleural Mesothelioma
por: Sayan, Muhammet, et al.
Publicado: (2022)

Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma
por: Zhang, Guozun, et al.
Publicado: (2020)

Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion
por: Zhang, Shu, et al.
Publicado: (2021)

A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern
por: Kerrigan, Kathleen, et al.
Publicado: (2022)

Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma
por: Yang, Yi-Lin, et al.
Publicado: (2015)

Thoracoscopy in Pleural Malignant Mesothelioma Diagnosis
por: Tassi, G. F., et al.
Publicado: (1997)

Imaging in staging of malignant pleural mesothelioma
por: Truong, Mylene T, et al.
Publicado: (2004)

Hedgehog Signaling in Malignant Pleural Mesothelioma
por: Felley-Bosco, Emanuela, et al.
Publicado: (2015)

Multimodality treatment of malignant pleural mesothelioma
por: Berzenji, Lawek, et al.
Publicado: (2018)

Modern management of malignant pleural mesothelioma
por: Patel, Shivani C, et al.
Publicado: (2016)

Pleural tuberculosis mimicking malignant mesothelioma
por: Dawood, Wajahat, et al.
Publicado: (2019)

Cytomegalovirus infection in malignant pleural mesothelioma
por: Hunter-Schlichting, DeVon, et al.
Publicado: (2021)

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
por: Terenziani, Rita, et al.
Publicado: (2021)

Advances in Immunotherapy of Malignant Pleural Mesothelioma
por: Liao, Dongying, et al.
Publicado: (2021)

KRAS signaling in malignant pleural mesothelioma
por: Marazioti, Antonia, et al.
Publicado: (2021)

ECM Mechanoregulation in Malignant Pleural Mesothelioma
por: Panzetta, Valeria, et al.
Publicado: (2022)

Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)

Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015)

Association of RERG Expression with Female Survival Advantage in Malignant Pleural Mesothelioma
por: De Rienzo, Assunta, et al.
Publicado: (2021)

Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma
por: Jiang, Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f2040l28ag2bv3cn6ioup309b6